Onderneming Guard Therapeutics International AB
Aandelen
GUARD
SE0021181559
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,4 SEK | +1,33% | +4,11% | -15,08% |
Vakgebied
Aantal werknemers: 11
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 01-12-18 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 14-09-20 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-01-22 |
Sara Thuresson
CTO | Chief Tech/Sci/R&D Officer | 48 | 24-05-21 |
Torbjörn Larsson
PRN | Corporate Officer/Principal | - | 01-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 01-05-21 |
Göran Forsberg
BRD | Director/Board Member | 61 | 29-05-19 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 01-12-22 |
Lars Höckenström
BRD | Director/Board Member | 68 | 23-10-19 |
Johannes Hulthe
BRD | Director/Board Member | 54 | 29-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 061 615 | 6 073 904 ( 60,37 %) | 0 | 60,37 % |
Bedrijfsgegevens
Guard Therapeutics International AB
Nybrogatan 34 2nd Floor
114 39, Stockholm
+46 86 70 65 51
http://www.guardtherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,08% | 27,91 mln. | |
+22,56% | 46,4 mld. | |
-1,51% | 41,75 mld. | |
+48,83% | 41,37 mld. | |
-3,42% | 29,71 mld. | |
+10,13% | 26,01 mld. | |
-20,44% | 19,52 mld. | |
+26,45% | 12,43 mld. | |
-0,14% | 12,18 mld. | |
-0,47% | 12,13 mld. |
- Beurs
- Aandelen
- Koers GUARD
- Onderneming Guard Therapeutics International AB